FREE PROSTATE-SPECIFIC ANTIGEN POSITIVE

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting FREE PROSTATE-SPECIFIC ANTIGEN POSITIVE:

# Drug Count
0 ABIRATERONE ACETATE 3
1 DOCETAXEL 3
2 DOCETAXEL ANHYDROUS 3
3 ENZALUTAMIDE 3
4 ABIRATERONE 2
5 AMITRIPTYLINE HYDROCHLORIDE 2
6 CABAZITAXEL 2
7 CARBOPLATIN 2
8 CYCLOPHOSPHAMIDE 2
9 CYCLOPHOSPHAMIDE FOR INJECTION 2
See all common drugs associated with FREE PROSTATE-SPECIFIC ANTIGEN POSITIVE

FREE PROSTATE-SPECIFIC ANTIGEN POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CABAZITAXEL 2 0.0006
1 MITOXANTRONE HYDROCHLORIDE 2 0.0003
2 AMITRIPTYLINE HYDROCHLORIDE 2 0.0001
3 ABIRATERONE ACETATE 3 0.0001
4 BICALUTAMIDE 1 0.0001
5 ENZALUTAMIDE 3 0.0001
6 HYDROXYUREA 1 0.0000
7 DOCETAXEL 3 0.0000
8 DOCETAXEL ANHYDROUS 3 0.0000
9 IBRUTINIB 2 0.0000
See all drugs enriched for association with FREE PROSTATE-SPECIFIC ANTIGEN POSITIVE

FREE PROSTATE-SPECIFIC ANTIGEN POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Androgen Receptor Inhibitor [EPC] 4 0.0001
1 Microtubule Inhibitor [EPC] 3 0.0000
2 Alkylating Drug [EPC] 2 0.0000
3 Platinum-based Drug [EPC] 2 0.0000
4 Thalidomide Analog [EPC] 2 0.0000
5 Kinase Inhibitor [EPC] 2 0.0000
6 Platelet Aggregation Inhibitor [EPC] 1 0.0000
7 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with FREE PROSTATE-SPECIFIC ANTIGEN POSITIVE